Skip to main content
Fanli Digital Technology Co., Ltd logo

Fanli Digital Technology Co., Ltd — Investor Relations & Filings

Ticker · 600228 ISIN · CNE000000Y78 Shanghai Stock Exchange Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 2,248 across all filing types
Latest filing 2021-03-19 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600228

About Fanli Digital Technology Co., Ltd

https://corp.fanli.com/

Fanli Digital Technology Co., Ltd. provides e-commerce integration and digital marketing services. The company operates a comprehensive platform that connects consumers with various online retail ecosystems through value-added services such as cash-back rewards, discount coupons, and promotional insights. Its core business model focuses on performance-based marketing, utilizing data-driven strategies to facilitate sales conversions for brand partners. Key offerings include brand promotion, user loyalty management, and targeted advertising solutions. By integrating diverse shopping channels into a single interface, the company optimizes the consumer purchasing journey and provides brands with scalable traffic acquisition tools. The platform serves as a strategic intermediary, leveraging user behavioral data to enhance marketing efficiency and provide measurable returns for merchants while delivering cost savings to a broad user base.

Recent filings

Filing Released Lang Actions
ST昌九关于公司会计政策变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Jiangxi Changjiu Bio-chemical Co., Ltd. regarding a change in accounting policy related to the adoption of a new lease accounting standard effective January 1, 2021. It details the reasons for the change, the nature of the new accounting policy, its impact on the company, and the approval process by the board and supervisory committee. The document is relatively short (2324 characters) and does not contain financial statements or detailed financial data. It is an announcement about a change in accounting policy rather than a full financial report or audit report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-03-19 Chinese
ST昌九第八届监事会第二次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Jiangxi Changjiu Bio-chemical Co., Ltd. It details the meeting dates, attendance, and resolutions passed regarding the 2020 annual supervisory work report, financial statements, profit distribution plan, annual report and summary, audit fees, internal control evaluation and audit reports, appointment of accounting firms, and accounting policy changes. The document does not contain the full annual report or financial statements but rather the decisions and approvals made by the supervisory board. It also references that the detailed reports are disclosed on the Shanghai Stock Exchange website. The document length is 2514 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is an official announcement of supervisory board resolutions and approvals related to the annual report and audit but does not contain the full annual report or detailed financial data itself.
2021-03-19 Chinese
2020年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as the 2020 annual report summary of Jiangxi Changjiu Bio-chemical Co., Ltd. It contains detailed financial data for the year 2020, including profit and loss, assets, cash flow, and shareholder information. It also discusses business operations, industry conditions, accounting policy changes, and consolidated subsidiaries. The presence of audited financial figures and comprehensive business analysis indicates this is a full annual report rather than a brief announcement or a partial report. The document length (8952 characters) and content depth support classification as an Annual Report (10-K equivalent). FY 2020
2021-03-19 Chinese
关于江西昌九生物化工股份有限公司非经营性资产占用及其他关联资金往来情况的专项说明中兴财光华审专字(2021)第213010号
Regulatory Filings
2021-03-19 Chinese
公司独立董事对公司当期及累计对外担保情况的专项说明及独立意见
Regulatory Filings Classification · 95% confidence The document is a special statement and independent opinion by the independent directors of Jiangxi Changjiu Bio-Chemical Co., Ltd. regarding the company's external guarantees during the reporting period. It references regulatory notices from the China Securities Regulatory Commission and discusses compliance with external guarantee regulations, confirming no violations or new guarantees during the period. The document is a formal attestation and opinion letter rather than a full financial report or audit. It is short (888 characters) and focuses on regulatory compliance and independent director opinion, fitting the category of Regulatory Filings (RNS) rather than a full Audit Report or Annual Report.
2021-03-19 Chinese
上海市方达律师事务所关于上海享锐企业管理咨询事务所(有限合伙)及其一致行动人免于发出要约事宜之法律意见书
Legal Proceedings Report Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding a specific transaction involving Shanghai Xiangrui Enterprise Management Consulting Partnership and its concerted actors, specifically about exemption from making a mandatory offer under the relevant Chinese securities regulations. It references detailed legal and regulatory frameworks, approvals by the board and shareholders, and compliance with the China Securities Regulatory Commission's approval. The document is a standalone legal opinion related to a major asset restructuring and share issuance transaction, not a financial report, earnings release, or general announcement. It does not contain financial statements or earnings data but focuses on legal compliance and qualification for exemption from a mandatory tender offer. This fits the category of Legal Proceedings Report (LTR) as it deals with legal opinions on regulatory compliance and transaction legality rather than financial or management reporting.
2021-03-19 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.